- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
2cureX AB (2CUREX)
2cureX AB stock price live, this page displays ST 2CUREX stock exchange data. View the 2CUREX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the 2cureX AB real time stock price chart below.
What Is the 2cureX AB Stock Price Today?
The 2cureX AB stock price today is 0.37.
What Is the Stock Symbol for 2cureX AB?
The stock symbol for 2cureX AB is "2CUREX."
What Stock Exchange Does 2cureX AB Trade On?
2cureX AB is listed and trades on the Stockholm stock exchange.
Is 2cureX AB a Good Stock to Buy?
Determining whether 2cureX AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2CUREX quote. (ISIN: SE0010468124)
What Is the 2cureX AB Stock Price Today?
The 2cureX AB stock price today is 0.37.
What Is the Stock Symbol for 2cureX AB?
The stock symbol for 2cureX AB is "2CUREX."
What Stock Exchange Does 2cureX AB Trade On?
2cureX AB is listed and trades on the Stockholm stock exchange.
Is 2cureX AB a Good Stock to Buy?
Determining whether 2cureX AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2CUREX quote. (ISIN: SE0010468124)
Stockholm
Currency in SEK
0.37
-0.01(-2.64%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.35
0.37
52 wk Range
0.20
0.88
2CUREX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.350.37
52 wk Range
0.200.88
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
2CUREX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
No news in this category
Looks like there are no results in this news category
2cureX Company Profile
2cureX AB (publ) operates as a medtech company in Europe. The company’s principal product is IndiTreat, an IVD test, which helps to predict cancer patient’s response and resistance to different drugs and select the appropriate treatment. It is also conducting various clinical programs for IndiTreat for colorectal, ovarian, and pancreatic cancers. The company was incorporated in 2006 and is based in Copenhagen, Denmark.
Compare 2CUREX to Peers and Sector
Metrics to compare | 2CUREX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2CUREXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.4x | −1.4x | −0.5x | |
PEG Ratio | −0.02 | −0.08 | 0.00 | |
Price/Book | 3.4x | 2.0x | 2.6x | |
Price / LTM Sales | 4.8x | 7.7x | 3.0x | |
Upside (Analyst Target) | - | 95.5% | 55.6% | |
Fair Value Upside | Unlock | 12.7% | 10.1% | Unlock |
Earnings
Latest Release
Feb 23, 2023
EPS / Forecast
-0.40 / --
Revenue / Forecast
82.00K / --
FAQ
What Is the 2cureX (2CUREX) Stock Price Today?
The 2cureX stock price today is 0.37.
What Stock Exchange Does 2cureX Trade On?
2cureX is listed and trades on the Stockholm stock exchange.
What Is the Stock Symbol for 2cureX?
The stock symbol for 2cureX is "2CUREX."
What Is the 2cureX Market Cap?
As of today, 2cureX market cap is 9.24M.
What is 2cureX Earnings Per Share?
The 2cureX EPS is -1.50.
From a Technical Analysis Perspective, Is 2CUREX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.